Coronavirus TriKE (GT Biopharma)

N/A

Report date: 2024/05/15 12:01:00

Base Information

Drug NameCoronavirus TriKE (GT Biopharma)
Drug Alias NameCoronavirus TriKE™
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNatural killer cells stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsIgG receptors modulators +[4] 
TargetsIgG receptorsAngiotensin-converting enzyme
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGt Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGt Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A